EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Examining the effect of universal testing and treatment strategies for HIV prevention in Zambia and South Africa: generalizing the results of the HPTN 071 (PopART) trial

Bonnie E Shook-Sa iD, Paul N Zivich, Stephen R Cole, Nora E Rosenberg, Michael G Hudgens, Deborah J Donnell, Sizulu Moyo, Khangelani Zuma, Helen Ayles, Peter Bock iD, Joseph J Eron, Richard J Hayes und 1 weitere

Journal of the International AIDS Society · 2025

DOI: 10.1002/jia2.70062 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the International AIDS Society, 2025. Verfasst von Bonnie E Shook-Sa und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: HIV Infections, HIV Testing. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, Cancer Research UK, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

HIV Prevention Trials Network (HPTN) 071 (PopART) was a cluster‐randomized trial to evaluate universal testing and treatment (UTT) strategies for HIV prevention. HPTN071 compared three arms: (A) combination prevention with UTT; (B) combination prevention with universal testing and antiretroviral therapy initiation according to local guidelines; and (C) standard of care (SOC). Interventions were implemented in entire randomized communities, with impacts on HIV incidence measured in “population cohorts,” that is the HPTN071 sample. Unexpectedly, a significantly lower incidence was not observed in arm A relative to SOC. Importantly, rates of participation in the HPTN071 sample differed among population subgroups, for example men were underrepresented.

Methods

To correct for underrepresented subgroups, PopART intervention effects are estimated in a population of interest, adults aged 18−44 in trial provinces, characterized with two nationally representative HIV‐focused surveys. The HPTN071 sample is weighted to match the population of interest by demographics and HIV risk factors. Risk of HIV acquisition is compared across arms, both in the trial population (unweighted) and the population of interest (weighted). Both (1) the risk of HIV acquisition between 1 and 3 years and (2) the risk of HIV acquisition by 3 years are compared.

Results

In the trial population, estimated risk in arm A is, counterintuitively, slightly higher than SOC (Year 1−3 Risk Difference [RD]: 0.10%; 95% CI: −1.15%, 1.25%). After weighting, risk in arm A is lower than SOC in the population of interest (RD: −0.34%; 95% CI: −2.04%, 0.96%). Weighting also strengthened the estimated effect in arm B relative to SOC (unweighted RD: −0.66%, 95% CI: −1.88%, 0.46%; weighted RD: −1.18%, 95% CI: −2.85%, 0.15%). Weighted year 3 risk difference estimates indicated even stronger possible intervention effects: A versus SOC −0.83% (95% CI: −2.94%, 0.99%), B versus SOC −1.86% (95% CI: −3.80%, −0.09%).

Conclusions

PopART interventions are estimated to be more protective in the population of interest than observed in the HPTN071 sample. These results partially explain the unexpected finding in arm A, providing further support for UTT strategies for HIV prevention. This analysis also highlights the importance of considering heterogeneous treatment effects among population subgroups when measuring the overall efficacy of HIV interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV TestingHumansMaleZambiaSouth AfricaAdultFemaleYoung AdultAdolescentIncidenceAnti-HIV Agents

Stichwörter der Autor:innen

HIVPopARTexternal validitygeneralizabilitypreventionuniversal testing and treatment

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Department of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Human Sciences Research Council, Pretoria, South Africa.

ORCID-Profile: Bonnie E Shook-Sa, Peter Bock, Jessie K Edwards

Förderung

  • NIH HHS
  • Cancer Research UK
  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Shook-Sa, B. E., Zivich, P. N., Cole, S. R., Rosenberg, N. E., Hudgens, M. G., Donnell, D. J., Moyo, S., Zuma, K., Ayles, H., Bock, P., Eron, J. J., Hayes, R. J., & Edwards, J. K. (2025). Examining the effect of universal testing and treatment strategies for HIV prevention in Zambia and South Africa: generalizing the results of the HPTN 071 (PopART) trial. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.70062

Vancouver

Shook-Sa BE, Zivich PN, Cole SR, Rosenberg NE, Hudgens MG, Donnell DJ, et al. Examining the effect of universal testing and treatment strategies for HIV prevention in Zambia and South Africa: generalizing the results of the HPTN 071 (PopART) trial. Journal of the International AIDS Society. 2025. doi:10.1002/jia2.70062

BibTeX
@article{ShookSa2025,
  author = {Shook-Sa, Bonnie E and Zivich, Paul N and Cole, Stephen R and Rosenberg, Nora E and Hudgens, Michael G and Donnell, Deborah J and Moyo, Sizulu and Zuma, Khangelani and Ayles, Helen and Bock, Peter and Eron, Joseph J and Hayes, Richard J and Edwards, Jessie K},
  title = {Examining the effect of universal testing and treatment strategies for HIV prevention in Zambia and South Africa: generalizing the results of the HPTN 071 (PopART) trial},
  journal = {Journal of the International AIDS Society},
  year = {2025},
  doi = {10.1002/jia2.70062}
}
Kostenlos starten →